| Revenue growth | 23% YoY for FY26 to ₹3,136 million. |
|---|---|
| Margins | Mature centres at 36-37%; overall FY26 EBITDA margin at 31.8%. |
| Demand visibility | Expanding into Genomics and acquiring Fetomat to drive specialized demand. |
| Management confidence | High, citing successful ramp-up of new centres and 36-37% mature margins. |
Growth
FY26 Revenue grew 23% YoY to ₹3,136M; Q4 EBITDA rose 26% YoY to ₹252M.
Outlook
Expansion plans for FY27 include 6 new hubs and 8 spokes across Bihar, Tripura, West Bengal, and Jharkhand.
Risks
Pre-operative expenses from 20 new centres impacting near-term margins; geographical concentration in West Bengal (95.5%).
Earnings Call filed with BSE, NSE: SURAKSHA. Summary written with AI assistance from the document.
Suraksha Diagnostic Ltd: key numbers
- Share price
- ₹320.15
- Market cap
- ₹1,667 Cr
- Revenue (annual)
- ₹310.4 Cr
- Net profit (annual)
- ₹32.19 Cr
- P/E (TTM)
- 46.6×Sector 53.1×
- Promoter holding
- 49.10%+0.00% QoQ
- FII holding
- 13.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Suraksha Diagnostic Ltd
All →Suraksha Diagnostic Annual General Meeting
Suraksha Diagnostic Ltd held its 21st AGM on September 22, 2026. Members adopted financial statements, approved a final dividend, and ratified cost auditor remuneration.
Suraksha Diagnostic Annual General Meeting
Suraksha Diagnostic Limited has issued a notice for its 21st Annual General Meeting scheduled for September 22, 2026, to conduct routine business and dividend declaration.
- Value
- ₹0.01 Cr
Suraksha Diagnostic Annual General Meeting
Suraksha Diagnostic Limited has issued a notice for its 21st Annual General Meeting to be held on September 22, 2026, to transact key corporate business.
Suraksha Diagnostic Other Announcement
Suraksha Diagnostic informed exchanges about dispatching letters to shareholders with unregistered emails, providing web links to access the 21st AGM notice and Annual Report.
Suraksha Diagnostic Annual Report
Suraksha Diagnostic Limited has filed its Annual Report for FY 2025-26, including the notice for the 21st Annual General Meeting scheduled for September 22, 2026.
Suraksha Diagnostic Earnings Call Transcript: Key Takeaways
Suraksha Diagnostic reported a robust Q1 FY27 with 21% revenue growth and 40% PAT growth, driven by expansion in West Bengal and Jharkhand and a high-growth genomics segment.
- Call
- Guides 15% growth